Page 67 - Breeding Edge ebook
P. 67
iRunway’s study also found DowDuPont leading the CRISPR global patent landscape with 514 IP
assets. This includes 216 patents filed by Dow Agrosciences (a wholly owned subsidiary of Dow
Chemical Company). DuPont filed 122 IP assets, while its subsidiaries Pioneer Hi-bred
International Inc. and Danisco filed 82 and 69 patents, respectively.
Harvard
University stood
second with 343
IP assets, of
which it filed
231 patents
independently
and 112 patents
filed in
collaboration
with Broad
Institute, with
most of its
patents co-assigned to Massachusetts Institute of Technology and Harvard University.
The report also noted that the technology areas of focus of all the leading assignees was very diverse.
While DowDuPont has focused its research in discovering bacterial sources for CRISPR array, a large
share of Broad Institute’s R&D is regarding engineered guide RNA and delivery vectors. And there is a
lot of diversity of IP assets across the globe.
www.Agri-Pulse.com 65
